![]() |
This Week in Addiction Medicine from ASAMAuthor: American Society of Addiction Medicine Language: en Genres: Health & Fitness, Medicine, Mental Health Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Lead: Patient-reported changes in alcohol use following glucagon-like peptide-1 receptor agonist initiation
Episode 242
Tuesday, 17 November, 2026
Patient-reported changes in alcohol use following glucagon-like peptide-1 receptor agonist initiation JAMA Psychiatry Using a nationally representative survey of US adults, this study estimated the population prevalence of patient-reported reductions in alcohol use following glucagon-like peptide-1 receptor agonist (GLP-1 RA) initiation and assessed public awareness of the potential impact of GLP-1 RAs on alcohol use. Researchers found that nearly half of individuals who used a GLP-1 RA reported they reduced their alcohol consumption; individuals with potentially unhealthy drinking were more likely to report reductions. Although large clinical trials are needed to draw conclusions about the relationship between GLP-1 RAs and alcohol use, it is notable that such a large fraction of GLP-1 users in this survey reported reductions. Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM













